Dr. Nirav Desai

Dr.Nirav is a biotech research professional with more than 18 years of industrial research experience in advancing Vaccines, Biologics and Diagnostic from PoC to commercialization. He has expertise in innovations, setting up PoC, process development, method development, technology transfer, facility start-up, and CRAMS management. He is experienced in all aspects of technical operations including large-scale bioreactor operations, downstream process and analytical development. He has been responsible for development of innovative cancer vaccines and immunomodulatorsand is currently developing Baculovirus-Sf9 system based Novel vaccines for Influenza, Rabies, EBOLA, MERS and Zika.

Niravcompleted his BS(Hons) in Microbiology and Biotechnology from the Mumbai University, India; MS (MSc) in Medical technology with Clinical Biochemistry from Narmad University, Surat, Indiaand PhD in Life sciences from Ahmedabad University, India.